The global bioresorbable scaffolds market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for bioresorbable scaffolds in various applications such as hospital and clinic, medical center, and others. Bioresorbable scaffolds are used in various surgical procedures such as hernia repair, spinal fusion surgery, and others. These scaffolds are made up of polymers that can be broken down by body enzymes or bacteria over time. This helps in reducing the risk of infection and other complications associated with traditional implants which cannot be removed once implanted into the body. The global bioresorbable scaffold market has been segmented on the basis of type into metabased bioresorbable scaffold and polymebased bioresorbable scaffold; on the basis of application into hospital & clinic, medical center; on the basis of region into North America (US, Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- Bioresorbable scaffolds are used in the treatment of a variety of diseases and injuries, including hernia repair, spinal fusion, and bone grafting.
- The increasing number of patients suffering from chronic diseases such as diabetes mellitus and obesity is driving the growth of the bioresorbable scaffolds market.
- Increasing awareness about bioresorbable scaffolds among physicians is also driving the growth of this market.
- The high cost associated with these products is one factor that may hamper the growth rate.
Industry Growth Insights published a new data on “Bioresorbable Scaffolds Market”. The research report is titled “Bioresorbable Scaffolds Market research by Types (Metal-based Bioresorbable Scaffold, Polymer-based Bioresorbable Scaffold), By Applications (Hospital & Clinic, Medical Center), By Players/Companies Abbott, Kyoto Medical, REVA Medical, Biotronik, Elixir Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioresorbable Scaffolds Market Research Report
By Type
Metal-based Bioresorbable Scaffold, Polymer-based Bioresorbable Scaffold
By Application
Hospital & Clinic, Medical Center
By Companies
Abbott, Kyoto Medical, REVA Medical, Biotronik, Elixir Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Bioresorbable Scaffolds Market Report Segments:
The global Bioresorbable Scaffolds market is segmented on the basis of:
Types
Metal-based Bioresorbable Scaffold, Polymer-based Bioresorbable Scaffold
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital & Clinic, Medical Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Kyoto Medical
- REVA Medical
- Biotronik
- Elixir Medical
Highlights of The Bioresorbable Scaffolds Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Metal-based Bioresorbable Scaffold
- Polymer-based Bioresorbable Scaffold
- By Application:
- Hospital & Clinic
- Medical Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioresorbable Scaffolds Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioresorbable scaffolds are a type of medical device that can be used to help heal wounds. They are made from natural or synthetic materials, and can dissolve in the body over time. This allows the scaffold to break down and be eliminated without causing any harm to the patient.
Some of the major players in the bioresorbable scaffolds market are Abbott, Kyoto Medical, REVA Medical, Biotronik, Elixir Medical.
The bioresorbable scaffolds market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bioresorbable Scaffolds Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bioresorbable Scaffolds Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bioresorbable Scaffolds Market - Supply Chain
4.5. Global Bioresorbable Scaffolds Market Forecast
4.5.1. Bioresorbable Scaffolds Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bioresorbable Scaffolds Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bioresorbable Scaffolds Market Absolute $ Opportunity
5. Global Bioresorbable Scaffolds Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bioresorbable Scaffolds Market Size and Volume Forecast by Type
5.3.1. Metal-based Bioresorbable Scaffold
5.3.2. Polymer-based Bioresorbable Scaffold
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bioresorbable Scaffolds Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bioresorbable Scaffolds Market Size and Volume Forecast by Application
6.3.1. Hospital & Clinic
6.3.2. Medical Center
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bioresorbable Scaffolds Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bioresorbable Scaffolds Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bioresorbable Scaffolds Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bioresorbable Scaffolds Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bioresorbable Scaffolds Demand Share Forecast, 2019-2026
9. North America Bioresorbable Scaffolds Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bioresorbable Scaffolds Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bioresorbable Scaffolds Market Size and Volume Forecast by Application
9.4.1. Hospital & Clinic
9.4.2. Medical Center
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bioresorbable Scaffolds Market Size and Volume Forecast by Type
9.7.1. Metal-based Bioresorbable Scaffold
9.7.2. Polymer-based Bioresorbable Scaffold
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bioresorbable Scaffolds Demand Share Forecast, 2019-2026
10. Latin America Bioresorbable Scaffolds Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bioresorbable Scaffolds Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bioresorbable Scaffolds Market Size and Volume Forecast by Application
10.4.1. Hospital & Clinic
10.4.2. Medical Center
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bioresorbable Scaffolds Market Size and Volume Forecast by Type
10.7.1. Metal-based Bioresorbable Scaffold
10.7.2. Polymer-based Bioresorbable Scaffold
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bioresorbable Scaffolds Demand Share Forecast, 2019-2026
11. Europe Bioresorbable Scaffolds Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bioresorbable Scaffolds Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bioresorbable Scaffolds Market Size and Volume Forecast by Application
11.4.1. Hospital & Clinic
11.4.2. Medical Center
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bioresorbable Scaffolds Market Size and Volume Forecast by Type
11.7.1. Metal-based Bioresorbable Scaffold
11.7.2. Polymer-based Bioresorbable Scaffold
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bioresorbable Scaffolds Demand Share, 2019-2026
12. Asia Pacific Bioresorbable Scaffolds Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bioresorbable Scaffolds Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bioresorbable Scaffolds Market Size and Volume Forecast by Application
12.4.1. Hospital & Clinic
12.4.2. Medical Center
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bioresorbable Scaffolds Market Size and Volume Forecast by Type
12.7.1. Metal-based Bioresorbable Scaffold
12.7.2. Polymer-based Bioresorbable Scaffold
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bioresorbable Scaffolds Demand Share, 2019-2026
13. Middle East & Africa Bioresorbable Scaffolds Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bioresorbable Scaffolds Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bioresorbable Scaffolds Market Size and Volume Forecast by Application
13.4.1. Hospital & Clinic
13.4.2. Medical Center
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bioresorbable Scaffolds Market Size and Volume Forecast by Type
13.7.1. Metal-based Bioresorbable Scaffold
13.7.2. Polymer-based Bioresorbable Scaffold
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bioresorbable Scaffolds Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bioresorbable Scaffolds Market: Market Share Analysis
14.2. Bioresorbable Scaffolds Distributors and Customers
14.3. Bioresorbable Scaffolds Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Kyoto Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. REVA Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biotronik
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Elixir Medical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook